Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Agile Therapeutics Inc AGRX

Alternate Symbol(s):  AGXRW

Healthcare
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a... see more

Recent & Breaking News (OTCPK:AGRX)

Agile Therapeutics Reports Third Quarter 2018 Financial Results

GlobeNewswire November 1, 2018

Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the 2018 North American Forum on Family Planning (NAFFP)

GlobeNewswire October 24, 2018

New Research Coverage Highlights MEDIFAST INC, Palo Alto Networks, Salesforce, Agile Therapeutics, Dicerna Pharmaceuticals, and Corbus Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire October 23, 2018

Thinking about buying stock in Agile Therapeutics, Advanced Micro Devices, Auris Medical Holding, Helios and Matheson Analytics Inc or Wells Fargo?

PR Newswire October 16, 2018

10 Hottest Stocks From October 15, 2018

Benzinga.com  October 15, 2018

46 Biggest Movers From Yesterday

Benzinga.com  October 10, 2018

10 Hottest Stocks From October 9, 2018

Benzinga.com  October 9, 2018

36 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  October 9, 2018

Mid-Day Market Update: Blackbaud Drops On Lowered FY18 Outlook; Agile Therapeutics Shares Surge

Benzinga.com  October 9, 2018

Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA

GlobeNewswire October 9, 2018

Agile Therapeutics Reports Second Quarter 2018 Financial Results

GlobeNewswire August 3, 2018

FDA’s Office of Drug Evaluation III Denies Agile Therapeutics, Inc.’s Initial Formal Dispute Resolution Request

GlobeNewswire July 24, 2018

Agile Therapeutics, Inc. Provides Corporate Update and Revised Cash Guidance

GlobeNewswire June 7, 2018

Mid-Afternoon Market Update: Applied Materials Falls On Weak Sales Forecast; Quotient Shares Spike Higher

Benzinga.com  May 18, 2018

Mid-Day Market Update: Shineco Rises After Q3 Results; Campbell Soup Shares Slide

Benzinga.com  May 18, 2018

Mid-Morning Market Update: Markets Mixed; Deere Misses Q2 Estimates

Benzinga.com  May 18, 2018

Consolidated Research: 2018 Summary Expectations for Verint, Mesabi Trust, Clearwater Paper, Agile Therapeutics, Community Trust, and Layne Christensen — Fundamental Analysis, Key Performance Indications

GlobeNewswire May 18, 2018

Agile Therapeutics, Inc. Provides Regulatory Update on Twirla® (AG200-15) for the Prevention of Pregnancy

GlobeNewswire May 18, 2018

Agile Therapeutics Reports First Quarter 2018 Financial Results

GlobeNewswire May 7, 2018

Agile Therapeutics to Host First Analyst Day on October 10, 2017

GlobeNewswire October 2, 2017